Elimian A, Verma U, Visintainer P, Tejani N
Department of Obstetrics and Gynecology and Graduate School of Health Sciences, New York Medical College, Valhalla, USA.
Obstet Gynecol. 2000 Jan;95(1):34-6. doi: 10.1016/s0029-7844(99)00471-8.
To compare effectiveness between single and multiple courses of antenatal steroids in preterm births and determine adverse effects attributable to multiple courses.
We studied retrospectively the neonatal outcomes of infants who weighed 1750 g or less at birth between January 1990 and December 1997. Infants exposed to a single course were compared with those exposed to two or more courses of antenatal steroids, with respect to various perinatal outcome variables.
Ninety-three neonates were exposed to two or more courses of antenatal steroids and 261 neonates had been given single courses. The mean (+/- standard deviation) gestational age (29.6 +/- 2.8 weeks compared with 28.7 +/- 2.7 weeks; P = .007) and birth weight (1252 +/- 321 g compared with 1159 +/- 339 g; P = .013) were significantly higher among neonates exposed to multiple courses. There were no significant differences between groups in perinatal outcomes; however, those exposed to multiple courses had a significantly lower rate of respiratory distress syndrome (RDS) (17 [18%] compared with 107 [41%]; P < or = .001) and surfactant use (40 [43%] compared with 149 [57%]; P = .02). Adjusting for confounding variables, multiple courses of steroids were significantly associated with a 65% reduction in the incidence of RDS (odds ratio 0.35; 95% confidence interval = 0.18, 0.70; P = .003).
Compared with single courses, multiple courses of antenatal steroids reduced significantly the incidence of RDS with no apparent increase in neonatal sepsis or disturbances in fetal growth.
比较单疗程与多疗程产前类固醇在早产中的疗效,并确定多疗程所致的不良反应。
我们回顾性研究了1990年1月至1997年12月期间出生体重在1750 g及以下的婴儿的新生儿结局。将接受单疗程的婴儿与接受两疗程或更多疗程产前类固醇的婴儿在各种围产期结局变量方面进行比较。
93例新生儿接受了两疗程或更多疗程的产前类固醇,261例新生儿接受了单疗程。接受多疗程的新生儿的平均(±标准差)胎龄(29.6±2.8周,相比28.7±2.7周;P = 0.007)和出生体重(1252±321 g,相比1159±339 g;P = 0.013)显著更高。两组在围产期结局方面无显著差异;然而,接受多疗程的新生儿呼吸窘迫综合征(RDS)发生率显著更低(17例[18%],相比107例[41%];P≤0.001),且表面活性剂使用情况也更低(40例[43%],相比149例[57%];P = 0.02)。对混杂变量进行校正后,多疗程类固醇与RDS发生率降低65%显著相关(优势比0.35;95%置信区间 = 0.18, 0.70;P = 0.003)。
与单疗程相比,多疗程产前类固醇显著降低了RDS的发生率,且新生儿败血症无明显增加,胎儿生长也无紊乱。